EMVO Appoints General Manager
EMVO appointed Andreas Walter general manager effective April 2016.
The European Medicines Verification Organization (EMVO) has appointed Andreas Walter as its general manager. Walter has been the interim director of EMVO since February 2015 and was recently appointed general manager effective April 2016. Walter comes from the European Federation of Pharmaceutical Industries and Associations (EFPIA) where he was the project director for the Falsified Medicines Directive.
“We welcome the appointment of Andreas Walter as EMVO General Manager who will help the pharmaceutical industry and supply chain get the system up and running effectively to ensure access to safe medicines for European patients,” said Sonia Ruiz, EMVO president, in a press announcement.
Source: EMVO
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Cosette Pharmaceuticals Adds to Dermatology and Women’s Health Portfolio with Mayne Pharma Purchase
Published: February 26th 2025 | Updated: February 26th 2025While the boards of directors of both companies have approved the transaction, it is not expected to close until the second quarter of 2025, as Mayne Pharma’s shareholders must still vote in favor of the acquisition.
FDA Approves First Treatment for Rare Lipid Storage Disease Cerebrotendinous Xanthomatosis
February 24th 2025Cerebrotendinous xanthomatosis, or CTX, is a metabolic disorder caused by a gene mutation that results in a deficiency of an important enzyme in the ability of the human body to break down fats.
